Endothelial cell infection and endotheliitis in COVID-19
Top Cited Papers
Open Access
- 20 April 2020
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 395 (10234), 1417-1418
- https://doi.org/10.1016/s0140-6736(20)30937-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently neededThe Lancet, 2020
- Offline: COVID-19—bewilderment and candourThe Lancet, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- The Assessment of Endothelial FunctionCirculation, 2012
- Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid ArthritisCirculation, 2008
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid ArthritisCirculation, 2002
- Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patientsJournal of Hypertension, 1998
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionThe New England Journal of Medicine, 1995